Related B cell clones that populate the CSF and CNS of patients with multiple sclerosis produce CSF immunoglobulin.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Neuroimmunology

• Publication date

  2011-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.jneuroim.2011.01.010PMID 21353315PMCID PMC3090654
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Related B cell clones populate the meninges and parenchyma of patients with multiple sclerosis.

  2011cited by this paper
• Epstein-Barr virus infection is not a characteristic feature of multiple sclerosis brain.

  2009cited by this paper
• Antibodies produced by clonally expanded plasma cells in multiple sclerosis cerebrospinal fluid

  2009cited by this paper
• Matching of oligoclonal immunoglobulin transcriptomes and proteomes of cerebrospinal fluid in multiple sclerosis

  2008cited by this paper
• Clonally expanded plasma cells in the cerebrospinal fluid of MS patients produce myelin‐specific antibodies

  2008cited by this paper
• Multiple sclerosis: T-cell receptor expression in distinct brain regions.

  2007cited by this paper
• Lipid microarrays identify key mediators of autoimmune brain inflammation

  2006cited by this paper
• B lineage cells in the inflammatory central nervous system environment: Migration, maintenance, local antibody production, and therapeutic modulation

  2006cited by this paper
• Multiple sclerosis.

  2005cited by this paper
• Receptor revision and atypical mutational characteristics in clonally expanded B cells from the cerebrospinal fluid of recently diagnosed multiple sclerosis patients.

  2005cited by this paper
• Antibodies from Inflamed Central Nervous System Tissue Recognize Myelin Oligodendrocyte Glycoprotein1

  2005cited by this paper
• Detection of Ectopic B‐cell Follicles with Germinal Centers in the Meninges of Patients with Secondary Progressive Multiple Sclerosis

  2004cited by this paper
• Protein microarrays guide tolerizing DNA vaccine treatment of autoimmune encephalomyelitis

  2003cited by this paper
• Accumulation of Clonally Related B Lymphocytes in the Cerebrospinal Fluid of Multiple Sclerosis Patients1

  2000cited by this paper
• B cell repertoire diversity and clonal expansion in multiple sclerosis brain lesions.

  1999cited by this paper
• Clonal expansion and somatic hypermutation of V(H) genes of B cells from cerebrospinal fluid in multiple sclerosis.

  1998cited by this paper
• Restricted use of VH4 Germline segments in an acute multiple sclerosis brain

  1998cited by this paper
• Patterns of oligodendroglia pathology in multiple sclerosis.

  1994cited by this paper
• Purification of autoantibodies to myelin basic protein by antigen specific affinity chromatography from cerebrospinal fluid IgG of multiple sclerosis patients. Immunoreactivity studies with human myelin basic protein.

  1991cited by this paper
• Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

  1987cited by this paper

• Meningeal B cells: Emerging players at the brain border.

  2026cites this paper
• Plasma cells in and around the central nervous system

  2026cites this paper
• Reduced CD40 expression in B cell subsets of individuals with radiologically isolated syndrome

  2025cites this paper
• Elevated ITGAX/CD11c in CSF-Derived Extracellular Vesicles Reflects Disability Progression in Multiple Sclerosis

  2025cites this paper
• The Elusive B Cell Antigen in Multiple Sclerosis: Time to Rethink CNS B Cell Functions

  2025cites this paper
• A review of laboratory practices for CSF oligoclonal banding and associated tests

  2025cites this paper
• CD19-targeted chimeric antigen receptor T cell therapy in two patients with multiple sclerosis.

  2024cites this paper
• Current state and perspectives of CAR T cell therapy in central nervous system diseases.

  2024cites this paper
• CD11c + B cells in relapsing–remitting multiple sclerosis and effects of anti‐CD20 therapy

  2024cites this paper
• Association between clinical characteristics, acute steroid treatment and oligoclonal bands result in multiple sclerosis: A retrospective study.

  2024cites this paper
• Expanded T lymphocytes in the cerebrospinal fluid of multiple sclerosis patients are specific for Epstein-Barr-virus-infected B cells

  2024cites this paper
• Cross-talk between B cells, microglia and macrophages, and implications to central nervous system compartmentalized inflammation and progressive multiple sclerosis

  2023cites this paper
• Cell-binding IgM in CSF is distinctive of multiple sclerosis and targets the iron transporter SCARA5

  2023cites this paper
• Neuro-immune crosstalk in depressive symptoms of multiple sclerosis.

  2023cites this paper
• B cell activating factor levels are linked to distinct B cell markers in multiple sclerosis and following B cell depletion and repopulation.

  2023cites this paper
• Selective emergence of antibody-secreting cells in the multiple sclerosis brain

  2023cites this paper
• Kappa free light chains index in multiple sclerosis very long-term prognosis

  2023cites this paper
• Bruton’s tyrosine kinase as a promising therapeutic target for multiple sclerosis

  2023cites this paper
• IL-10-providing B cells govern pro-inflammatory activity of macrophages and microglia in CNS autoimmunity

  2023cites this paper
• Neurodegeneration in multiple sclerosis

  2022cites this paper
• Novel somatic single nucleotide variants within the RNA binding protein hnRNP A1 in multiple sclerosis patients [version 2; peer review: 3 approved]

  2022cites this paper
• B-cells expressing NgR1 and NgR3 are localized to EAE-induced inflammatory infiltrates and are stimulated by BAFF

  2021cites this paper
• Immunology of Multiple Sclerosis

  2021cites this paper
• Main Role of Antibodies in Demyelination and Axonal Damage in Multiple Sclerosis

  2021cites this paper
• Stereotyped B-cell responses are linked to IgG constant region polymorphisms in multiple sclerosis

  2021cites this paper
• Rituximab for the treatment of multiple sclerosis: a review

  2021cites this paper
• Next Generation Sequencing of Cerebrospinal Fluid B Cell Repertoires in Multiple Sclerosis and Other Neuro-Inflammatory Diseases—A Comprehensive Review

  2021cites this paper
• AN EVALUATION OF PATIENTS DIAGNOSED WITH OPTIC NEURITIS IN CHILDHOOD

  2021cites this paper
• Differential Effects of MS Therapeutics on B Cells—Implications for Their Use and Failure in AQP4-Positive NMOSD Patients

  2020cites this paper
• E.U. paediatric MOG consortium consensus: Part 3 - Biomarkers of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders.

  2020cites this paper
• E.U. paediatric MOG consortium consensus: Part 5 - Treatment of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders.

  2020cites this paper
• Generation of a Model to Predict Differentiation and Migration of Lymphocyte Subsets under Homeostatic and CNS Autoinflammatory Conditions

  2020cites this paper
• Multiplex assessment of cerebrospinal fluid biomarkers in multiple sclerosis.

  2020cites this paper
• The Role of Antibodies in the Pathogenesis of Multiple Sclerosis

  2020cites this paper
• Regulation of neuroinflammation by B cells and plasma cells

  2020cites this paper
• Multiple Sclerosis

  2020cites this paper
• Plasmapheresis for Multiple Sclerosis in the Twenty-First Century: Take It or Leave It?

  2020cites this paper
• Modification of CSF findings in multiple sclerosis in the era of rapidly expanding treatment options

  2019cites this paper
• Place des échanges plasmatiques dans la sclérose en plaques et la neuromyélite optique

  2019cites this paper
• Persistence of intrathecal oligoclonal B cells and IgG in multiple sclerosis.

  2019cites this paper
• B cell depletion in the treatment of multiple sclerosis

  2019influential citation
• Impact of B cells to the pathophysiology of multiple sclerosis

  2019cites this paper
• CSF Free Light Chains as a Marker of Intrathecal Immunoglobulin Synthesis in Multiple Sclerosis: A Blood-CSF Barrier Related Evaluation in a Large Cohort

  2019cites this paper
• B cells in autoimmune and neurodegenerative central nervous system diseases

  2019cites this paper
• The role of B cells in multiple sclerosis: Current and future therapies.

  2019cites this paper
• Placing CD20-targeted B cell depletion in multiple sclerosis therapeutic scenario: Present and future perspectives.

  2019cites this paper
• An Overview of the Intrinsic Role of Citrullination in Autoimmune Disorders

  2019cites this paper
• Longitudinally persistent cerebrospinal fluid B cells can resist treatment in multiple sclerosis.

  2019cites this paper
• Association of cerebrospinal fluid kappa free light chains with the intrathecal polyspecific antiviral immune response in multiple sclerosis.

  2019cites this paper
• The compartmentalized inflammatory response in the multiple sclerosis brain is composed of tissue-resident CD8+ T lymphocytes and B cells

  2018cites this paper
• Longitudinally persistent cerebrospinal fluid B-cells resist treatment in multiple sclerosis

  2018cites this paper
• Safety and Efficacy of Rituximab: Experience of a Single Multiple Sclerosis Center

  2018cites this paper
• Multiple Sclerosis: B Cells Take Center Stage

  2018cites this paper
• Human central nervous system astrocytes support survival and activation of B cells: implications for MS pathogenesis

  2018cites this paper
• MicroRNAs: Roles in Regulating Neuroinflammation

  2018cites this paper
• B‐cell Therapy for Multiple Sclerosis: Entering an era

  2018cites this paper
• Oligoclonal bands in multiple sclerosis; Functional significance and therapeutic implications. Does the specificity matter?

  2018cites this paper
• Learning from other autoimmunities to understand targeting of B cells to control multiple sclerosis.

  2018cites this paper
• B-cell composition in the blood and cerebrospinal fluid of multiple sclerosis patients treated with dimethyl fumarate.

  2018cites this paper
• Investigation of the adaptive immune response in multiple sclerosis

  2018cites this paper
• Factors promoting B cell activation and accumulation in the inflamed CNS

  2017cites this paper
• Effects of dimethyl fumarate in two animal models of MS

  2017cites this paper
• Targets of therapy in progressive MS

  2017cites this paper
• A Haystack Heuristic for Autoimmune Disease Biomarker Discovery Using Next-Gen Immune Repertoire Sequencing Data

  2017cites this paper
• The Role of Brain-Reactive Autoantibodies in Brain Pathology and Cognitive Impairment

  2017cites this paper
• In Silico Prediction Analysis of Idiotope-Driven T–B Cell Collaboration in Multiple Sclerosis

  2017cites this paper
• The chronically inflamed central nervous system provides niches for long-lived plasma cells

  2017cites this paper
• B-cell–targeted therapies in relapsing forms of MS

  2017cites this paper
• BAFF Index and CXCL13 levels in the cerebrospinal fluid associate respectively with intrathecal IgG synthesis and cortical atrophy in multiple sclerosis at clinical onset

  2017cites this paper
• Multiple sclerosis: Presence of serum antibodies to lipids and predominance of cholesterol recognition

  2017cites this paper
• Biomarcadores predictivos en esclerosis múltiple

  2017influential citation
• Inflammatory demyelinating diseases of the central nervous system

  2017cites this paper
• Cerebrospinal fluid B cells and disease progression in multiple sclerosis - A longitudinal prospective study

  2017cites this paper
• Tertiary Lymphoid Organs in Central Nervous System Autoimmunity

  2016cites this paper
• Detection of intrathecal immunoglobulin G synthesis by capillary isoelectric focusing immunoassay in oligoclonal band negative multiple sclerosis

  2016cites this paper
• Distinct oligoclonal band antibodies in multiple sclerosis recognize ubiquitous self-proteins

  2016cites this paper
• Epstein-Barr virus and multiple sclerosis. From evidence to therapeutic strategies.

  2016cites this paper
• The search for the target antigens of multiple sclerosis, part 2: CD8+ T cells, B cells, and antibodies in the focus of reverse-translational research.

  2016cites this paper
• The role of B cells in multiple sclerosis: more than antibodies.

  2016cites this paper
• Multiple Sclerosis: Where Do We Go From Here?

  2016cites this paper
• The blood-brain barrier.

  2016cites this paper
• AWARD NUMBER: W81XWH-14-1-0369 TITLE: Maternal Brain-Reactive Antibodies and Autism Spectrum Disorder PRINCIPAL INVESTIGATOR: Betty Diamond CONTRACTING ORGANIZATION: Feinstein Institute for Medical Research

  2016cites this paper
• High‐throughput sequencing of immune repertoires in multiple sclerosis

  2016cites this paper
• Meningeal Tertiary Lymphoid Tissues and Multiple Sclerosis: A Gathering Place for Diverse Types of Immune Cells during CNS Autoimmunity

  2016cites this paper
• Intrathecal lipid-specific oligoclonal IgM synthesis associates with retinal axonal loss in multiple sclerosis.

  2016cites this paper
• B Lymphocytes in Multiple Sclerosis: Bregs and BTLA/CD272 Expressing-CD19+ Lymphocytes Modulate Disease Severity

  2016cites this paper
• Role of B Cells in the Pathogenesis of Multiple Sclerosis

  2016cites this paper
• INDIRIZZO IN NEUROSCIENZE XXVIII CICLO “INTEGRATION OF ADVANCED MOLECULAR ANALYSES AND MAGNETIC RESONANCE IMAGING FOR THE IDENTIFICATION OF BIOMARKERS OF DISEASE PROGRESSION IN MULTIPLE SCLEROSIS”

  2016cites this paper
• Capillary isoelectric focusing immunoassay as a new nanoscale approach for the detection of oligoclonal bands

  2015cites this paper
• B Cells in the Multiple Sclerosis Central Nervous System: Trafficking and Contribution to CNS-Compartmentalized Inflammation

  2015cites this paper
• The Ins and Outs of B Cells in Multiple Sclerosis

  2015cites this paper
• IFN-β and multiple sclerosis: cross-talking of immune cells and integration of immunoregulatory networks.

  2015cites this paper
• Update on the Autoimmune Pathology of Multiple Sclerosis: B-Cells as Disease-Drivers and Therapeutic Targets

  2015cites this paper
• Investigating the Antigen Specificity of Multiple Sclerosis Central Nervous System-Derived Immunoglobulins

  2015cites this paper
• Latitude and HLA-DRB1 alleles independently affect the emergence of cerebrospinal fluid IgG abnormality in multiple sclerosis

  2015cites this paper
• The cerebrospinal fluid immunoglobulin transcriptome and proteome in neuromyelitis optica reveals central nervous system-specific B cell populations

  2015cites this paper
• Progressive multiple sclerosis 1 Pathological mechanisms in progressive multiple sclerosis

  2015cites this paper
• Neuroinflammation: Ways in Which the Immune System Affects the Brain

  2015cites this paper
• B Cells Are Multifunctional Players in Multiple Sclerosis Pathogenesis: Insights from Therapeutic Interventions

  2015cites this paper
• [Meningeal tertiary lymphoid organs: Major actors in intrathecal autoimmunity].

  2015cites this paper